MedTrace Logo

AVL200 IOL for Treatment of Cataract and Presbyopia

NCT05627700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2026-02-20

No results posted yet for this study

Summary

This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.

Conditions

  • Cataract

Interventions

DEVICE

AVL200 IOL

The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.

Sponsors & Collaborators

  • Atia Vision

    lead INDUSTRY

Principal Investigators

  • Ashvin Agarwal, MD · Dr. Agarwals Eye Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2025-12-30
Completion
2026-02-10
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05627700 on ClinicalTrials.gov